BSE filing, NSE: ARTEMISMED. Summary written from the filing by ALFA Finder's alert engine.
Artemis Medicare Services Ltd: key numbers
- Share price
- ₹297.40
- Market cap
- ₹4,708 Cr
- Revenue (annual)
- ₹1,081 Cr
- Net profit (annual)
- ₹103.6 Cr
- P/E (TTM)
- 41.4×Sector 52.0×
- Promoter holding
- 58.39%+0.00% QoQ
- FII holding
- 12.45%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Artemis Medicare Services Ltd
All →Artemis Medicare Services Other Announcement
Artemis Medicare Services Ltd submitted its quarterly shareholding pattern for the period ending September 30, 2026, in compliance with SEBI regulatory requirements.
Artemis Medicare Services Legal & Regulatory
Artemis Medicare received a Rs. 11.11 Crore Show Cause Notice from the GST department. The company is contesting this through a writ petition.
- Value
- ₹11.11 Cr
Artemis Medicare Services Credit Rating
CARE Ratings reaffirmed Artemis Medicare's bank facility ratings at CARE A with Stable outlook. Long-term and short-term facilities totalling ₹388.15 Cr were reviewed.
Artemis Medicare Services Earnings Call Transcript: Key Takeaways
Artemis reports strong Q1 FY27 growth, driven by Gurgaon performance and the Raipur hospital launch. Management is pivoting toward high-end quaternary care with a massive 2,000-bed expansion target by 2030.
Artemis Medicare Services Capacity Expansion: ₹180 Cr Investment
Artemis Medicare Services will invest ₹180 Crore to add 200+ beds at its Gurugram hospital, focusing on pediatric and gynecological services.
- Value
- ₹180.0 Cr
- Execution
- ~ 2 years
Artemis Medicare Services Other Announcement
Artemis Medicare Services filed its Monitoring Agency Report for the quarter ended June 30, 2026, regarding the utilization of proceeds from its past Preferential Issue.
Other board meeting date announcements
All →Sea TV Network Board Meeting Date
Sea TV Network set a board meeting for 4 November 2026 to consider Q2 and half-year results. Agenda covers internal auditor change and a company secretary authorisation.
Sundaram Brake Lining Board Meeting Date
Sundaram Brake Linings will hold a board meeting on 13 November 2026 to consider unaudited standalone financial results for the half year ended September 2026. The trading window is closed from 1 October to 17 November 2026.
Narmadesh Brass Industries Board Meeting Date
Narmadesh Brass Industries will hold a board meeting on 3 November 2026 to consider unaudited standalone results for the half year ended 30 September 2026. The filing is an advance board meeting intimation.
Panabyte Technologies Board Meeting Date
Panabyte Technologies scheduled a board meeting for November 5, 2026 to consider unaudited standalone quarterly results. Agenda items are proposed only, with no decision yet taken.
Texmaco Rail & Engineering Board Meeting Date
Texmaco Rail & Engineering will hold a board meeting on November 5, 2026 to consider unaudited standalone and consolidated results for Q2 and H1 FY27. No financial figures are disclosed in this intimation.
Sundaram-Clayton Board Meeting Date
Sundaram-Clayton convenes a board meeting on 4 November 2026 to consider quarterly results. Trading window stays closed until 6 November 2026.